We are live on !
Find out more
BCA
Burren Capital Advisors Portfolio holdings
AUM
$33M
Turnover
85.19%
1-Year Est. Return
47.67%
This Fund
S&P 500
This Quarter Est. Return
+14.82%
1 Year Est. Return
+47.67%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$33M
AUM Growth
-$1.24M
(-3.6%)
Cap. Flow
+$77K
Cap. Flow % of AUM
Cap. Flow %
0.23%
Top 10 Holdings %
Top 10 Hldgs %
87.67%
Holding
27
New
12
Increased
–
Reduced
2
Closed
11
Avg Time Held
0.1
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VRNA
Verona Pharma
VRNA
|
+$6.6M |
| 2 |
Verint Systems
VRNT
|
+$4.34M |
| 3 |
TXNM Energy Inc
TXNM
|
+$3.59M |
| 4 |
Air Lease Corp
AL
|
+$3.25M |
| 5 |
ZimVie
ZIMV
|
+$1.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Skechers
SKX
|
+$4.41M |
| 2 |
Walgreens Boots Alliance
WBA
|
+$2.81M |
| 3 |
Hess
HES
|
+$2.42M |
| 4 |
Kellanova
K
|
+$2.38M |
| 5 |
NV5 Global
NVEE
|
+$1.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.37% |
| 2 | Technology | 20.67% |
| 3 | Utilities | 10.83% |
| 4 | Industrials | 10.49% |
| 5 | Communication Services | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
VRNA
1
DELISTED
Verona Pharma
VRNA
| $6.74M | 20.43% |
+63,198
| New | +$6.6M |
2025 Q3
0 quarters
|
|
|
2
DELISTED
Verint Systems
VRNT
| $4.27M | 12.92% |
+210,660
| New | +$4.34M |
2025 Q3
0 quarters
|
|
|
3
TXNM Energy Inc
TXNM
$6.44B
| $3.57M | 10.83% |
+63,198
| New | +$3.59M |
2025 Q3
0 quarters
|
|
|
4
DELISTED
Air Lease Corp
AL
| $3.46M | 10.49% |
+54,421
| New | +$3.25M |
2025 Q3
0 quarters
|
|
5
DELISTED
Frontier Communications
FYBR
| $3.31M | 10.04% |
88,729
| – | – |
2025 Q1
2 quarters
|
|
|
6
DELISTED
Kellanova
K
| $2.15M | 6.51% |
54,185
-29,936
| -36% | -$2.38M |
2025 Q1
2 quarters
|
|
|
7
DELISTED
ZimVie
ZIMV
| $1.99M | 6.04% |
+105,330
| New | +$1.78M |
2025 Q3
0 quarters
|
|
8
DELISTED
AvidXchange
AVDX
| $1.39M | 4.22% |
139,842
| – | – |
2025 Q2
1 quarter
|
|
9
DELISTED
Synovus
SNV
| $1.03M | 3.13% |
+21,066
| New | +$1.08M |
2025 Q3
0 quarters
|
|
10
DELISTED
Surmodics
SRDX
| $1.01M | 3.05% |
33,664
-2,182
| -6% | -$72.8K |
2025 Q1
2 quarters
|
|
11
DELISTED
ODP
ODP
| $973K | 2.95% |
+34,955
| New | +$718K |
2025 Q3
0 quarters
|
|
12
DELISTED
Premier
PINC
| $972K | 2.94% |
+34,955
| New | +$844K |
2025 Q3
0 quarters
|
|
13
DELISTED
Dayforce
DAY
| $726K | 2.2% |
+10,533
| New | +$656K |
2025 Q3
0 quarters
|
|
14
STAAR Surgical
STAA
$1.1B
| $660K | 2% |
+24,577
| New | +$586K |
2025 Q3
0 quarters
|
|
15
Core Scientific
CORZ
$4.41B
| $441K | 1.34% |
+24,577
| New | +$360K |
2025 Q3
0 quarters
|
|
16
DELISTED
Cross Country Healthcare
CCRN
| $298K | 0.9% |
+20,973
| New | +$277K |
2025 Q3
0 quarters
|
|
17
DELISTED
Amedisys
AMED
| – | – |
-13,949
| Closed | -$1.37M | – |
|
18
DELISTED
Couchbase
BASE
| – | – |
-73,417
| Closed | -$1.79M | – |
|
19
DELISTED
ChampionX
CHX
| – | – |
-45,365
| Closed | -$1.13M | – |
|
20
DELISTED
Dun & Bradstreet
DNB
| – | – |
-153,826
| Closed | -$1.4M | – |
|
|
21
DELISTED
Hess
HES
| – | – |
-17,480
| Closed | -$2.42M | – |
|
22
DELISTED
Informatica
INFA
| – | – |
-57,335
| Closed | -$1.4M | – |
|
23
DELISTED
Juniper Networks
JNPR
| – | – |
-45,449
| Closed | -$1.81M | – |
|
|
24
DELISTED
NV5 Global
NVEE
| – | – |
-82,095
| Closed | -$1.9M | – |
|
|
25
DELISTED
Skechers
SKX
| – | – |
-69,921
| Closed | -$4.41M | – |
|
Similar funds
VM
TCM
AECF
PI
HCM
OC
VVA
AM
Burren Capital Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Burren Capital Advisors held 27 positions worth $33M, down 3.6% from $34.2M the previous quarter. Its ten largest holdings account for 88% of the portfolio.
Burren Capital Advisors's Q3 2025 filing shows 12 new, 2 reduced and 11 closed positions. Its largest new stake was Verona Pharma: 63,198 shares worth $6.74M. The largest sale was Skechers, an estimated $4.41M.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 15% a quarter earlier, followed by Technology and Utilities.
- Burren Capital Advisors's largest Q3 2025 buy was Verona Pharma: 63,198 shares worth $6.74M.
- Burren Capital Advisors's biggest Q3 2025 reduction was Kellanova, cutting an estimated $2.38M.
- Burren Capital Advisors fully exited Skechers in Q3 2025, selling an estimated $4.41M.
- Burren Capital Advisors's ten largest holdings make up 88% of its $33M portfolio in Q3 2025.
- Burren Capital Advisors opened 12 new positions and closed 11 in Q3 2025.
- Burren Capital Advisors's portfolio value fell 3.6% quarter-over-quarter to $33M.
Based on Burren Capital Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.